Company & Sponsor Intelligence
Emory University
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials1
Recruiting0
Completed0
Countries1
Therapeutic footprint
autism
Indexed studies
NCT02646982Candesartan's Effects on Alzheimer's Disease And Related Biomarkers
alzheimers · United StatesPHASE2
alzheimers · United StatesPHASE2
NCT01985022Changing Developmental Trajectories Through Early Treatment
autism · United StatesNA
autism · United StatesNA
Intelligence layer updated: 2026-06-10 02:57:56.223123+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →